Biotech & Medtech news — Thursday 05 November 2026 — 34 stories

Why the Wealth of Data From Wearables Are Important for Consumers and Clinicians

MedCity News 23:00 UTC

Growing use of wearable technologies and the data they produce was discussed by a panel at the MedCity News INVEST Digital Health Conference in Dallas. The post Why the Wealth of Data From Wearables Are Important for Consumers and…

STAT+: Pharma’s trade group spent heavily on search ads to sway public opinion

STAT News 21:36 UTC

The lobbying group for the U.S. pharmaceutical industry spent an estimated $59 million on search advertising over a recent seven-year period to influence how Americans view the highly charged issue of prescription drug costs, according to…

Medicare will cut billions from 340B, expand site-neutral payments in 2027

BioPharma Dive 21:06 UTC

Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.

Ballot measures affirm divisions over abortion and transgender issues

STAT News 20:49 UTC

The blue wave that handed Democrats power in both the House and Senate did not filter neatly through ballot measures across the country. Measures on abortion, marijuana, science funding, and Medicaid largely reflected a more liberal…

Child dies of measles in Wisconsin’s first such death since 1990

STAT News 20:31 UTC

MADISON, Wis. — An infant in southwestern Wisconsin has died after contracting measles , the state’s first death from the disease in 36 years, state officials announced Thursday. The Wisconsin Department of Health Services did not specify…

STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy

STAT News 18:53 UTC

Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, a surprising development that has raised concerns among families, physicians…

STAT+: Stunning $6M defamation verdict reverberates at MIT campus, global scientific community

STAT News 18:19 UTC

The explosive court battle between a former star scientist at the Massachusetts Institute of Technology and a younger colleague continues to roil the Cambridge campus, with some contending the $6 million defamation judgment against the…

STAT+: Two No Surprises Act arbitrators lose government contracts to decide payment disputes

STAT News 18:09 UTC

WASHINGTON — The Trump administration is cutting off two groups tasked with arbitrating disputes over surprise medical bills, citing a failure “to meet minimum performance standards.” The groups, Island Peer Review Organization, or IPRO…

Opinion: MAHA 1.0 is dead. MAHA 2.0 is born

STAT News 18:00 UTC

Since Tuesday night, the obituaries for the MAHA movement have been piling up fast: “ RFK Jr and MAHA Suffer Brutal Election Night Wipeout ,” wrote the Daily Beast. Midterms could be the “‘death knell’ of the MAHA-Trump alliance,”…

At ASH, drugmakers to showcase early data for three-pronged cancer therapies

BioPharma Dive 17:09 UTC

J&J and AbbVie are among the companies advancing “trispecific” antibodies that could become another step forward in treatment for multiple myeloma.

STAT+: A possible comeback for a failed sickle cell gene therapy

STAT News 16:22 UTC

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The news is newsing hard these days, no? China hits the brakes on controversial trials China’s fast, cheap route to…

Revolution’s Rasonque off to best cancer drug launch ‘in history’

BioPharma Dive 16:21 UTC

Wall Street analysts are already resetting projections for Rasonque — but company executives cautioned that it’s too early to draw conclusions about the pancreatic cancer drug’s launch trajectory.

STAT+: Winners, losers, and MAHA

STAT News 15:41 UTC

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Welp. Send news tips and a life…

AI Didn’t Reduce Clinician Burden — It Just Moved It

MedCity News 14:51 UTC

Documentation tools have value. They solve a visible pain point well. But solving a visible pain point is not the same as solving the right one. The post AI Didn’t Reduce Clinician Burden — It Just Moved It appeared first on MedCity News .

STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more

STAT News 14:49 UTC

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every new day should be…

The Dangerous Illusion of the “Two-Week AI Expert”: A Call to Action Against Superficial Medical Education

MedCity News 14:27 UTC

If we choose the quick fix, let us be honest about the consequences: when an unexamined algorithm leads to a fatal diagnostic error, the blame will not lie with the black box. It will lie with us, because we were too reckless to teach the…

The AI-Native Clinician Is Already Here. Medical Education and Health Systems Need to Catch Up.

MedCity News 14:10 UTC

[Sponsored] Medical students, residents, and fellows are not waiting for formal guidance on artificial intelligence before putting it to use. The post The AI-Native Clinician Is Already Here. Medical Education and Health Systems Need to…

When Medicaid’s Data Can’t Verify Eligibility, Members Shouldn’t Lose Coverage

MedCity News 14:03 UTC

When verification fails and an eligible member loses coverage, treatment can be interrupted, medications can go unfilled and manageable conditions can become medical emergencies. The post When Medicaid’s Data Can’t Verify Eligibility…

STAT+: Beyond statins, one drug lowered heart attack risk by 20%

STAT News 14:00 UTC

When statins aren’t enough, other cholesterol-lowering drugs come into play. But which one is most effective? Cardiologists looking to help their patients reduce the amount of LDL, or “bad,” cholesterol threatening to clog their coronary…

STAT+: Medicare delays controversial RPM rule update

STAT News 13:04 UTC

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! Below…

Single-payer health care system proponents were thrown a big bone this election

STAT News 12:58 UTC

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . We’ve got great stories below that flesh out the implications of the Democrats’ rout in the midterm elections. But if…

T-Therapeutics reloads with a $133M megaround for bispecifics

BioPharma Dive 12:52 UTC

The startup is built around technology it claims can help get after known, but undruggable cancer targets and design particularly selective autoimmune disease treatments.

STAT+: Revolution’s pancreatic cancer drug has stunning commercial debut

STAT News 12:33 UTC

The commercial debut of Revolution Medicines’ pancreatic cancer drug Rasonque was eye-popping and jaw-dropping: $198 million in sales in just five weeks following the U.S. approval of the groundbreaking pan-RAS inhibitor. More than 5,000…

STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug

STAT News 11:30 UTC

This story first appeared in Adam’s Biotech Scorecard, a STAT newsletter. Sign up here to get it delivered to your inbox. And subscribe to STAT+ to get an unabridged version, with exclusive content. Shares of ProMis Neurosciences…

STAT+: What the midterms could mean for the future of health AI

STAT News 09:30 UTC

Tuesday’s midterm elections highlighted the negative sentiment around artificial intelligence, with voters roundly rejecting the data centers required to power the technology on dozens of ballot measures across several states. The results…

STAT+: As more doctors consult chatbots, health systems can block them — or buy in

STAT News 09:30 UTC

Earlier this year, Patrick Woodard had to have a talk with one of the hundreds of clinicians that work at Monument Health, where he is chief information officer. The South Dakota and Wyoming-based health system had decided to block access…

STAT+: In China, a flood of controversial clinical trials slows to a trickle

STAT News 09:30 UTC

SHANGHAI — Juan Huang noticed her 13-year-old daughter, Huangxi, was leaning out of her stroller, so she undid the buckles, scooped her out, and laid the length of her — long, loose, rail thin — across her lap. In 2014, doctors here had no…

Opinion: I’m a neurosurgeon. I’ve learned pain and suffering are very different things

STAT News 09:30 UTC

John (not his real name) was in his mid-60s, a VA patient with chronic back pain. After three surgeries by three different surgeons over about five years, he was no better off; his lumbar spine was littered with arthritis and titanium…

Alethio raises $90M to target rare blood cancers

BioPharma Dive 08:00 UTC

The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.

Adaptive Multi Mode: Budget-Aware Routing of Optimizers By Online Landscape Probes